Teva introduces psoriasis drug

Drug maker introduces generic version of GSK's Soriatane

NORTH WALES, Pa. — Drug maker Teva Pharmaceutical Industries has introduced acitretin capsules, the company said.

Teva announced the availability of the capsules in the 10-mg, 17.5-mg and 25-mg strengths, in bottle sizes of 30.

The drug is a generic version of Soriatane and is used to treat psoriasis. Soriatane is made by Stiefel, a division of GlaxoSmithKline.

Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

Login or Register to post a comment.